Patents by Inventor Chad Schroeder

Chad Schroeder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10532999
    Abstract: The present technology relates to compounds and compositions of Formulas I-III and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).
    Type: Grant
    Filed: October 1, 2018
    Date of Patent: January 14, 2020
    Assignees: UNIVERSITY OF KANSAS, UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, SOUTHERN RESEARCH INSTITUTE
    Inventors: Jennifer Golden, Jeffrey Aube, Donghoon Chung, Chad Schroeder, Tuanli Yao, E. Lucile White, Nichole A. Tower
  • Publication number: 20190270730
    Abstract: The present technology relates to compounds and compositions of Formulas I-III and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).
    Type: Application
    Filed: October 1, 2018
    Publication date: September 5, 2019
    Inventors: Jennifer Golden, Jeffrey Aube, Donghoon Chung, Chad Schroeder, Tuanli Yao, E. Lucile White, Nichole A. Tower
  • Patent number: 10087168
    Abstract: The present technology relates to compounds and compositions of Formulas I-III and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).
    Type: Grant
    Filed: February 27, 2017
    Date of Patent: October 2, 2018
    Assignees: UNIVERSITY OF KANSAS, UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC., SOUTHERN RESEARCH INSTITUTE
    Inventors: Jennifer Golden, Jeffrey Aube, Donghoon Chung, Chad Schroeder, Tuanli Yao, E. Lucile White, Nichole A. Tower
  • Publication number: 20170166557
    Abstract: The present technology relates to compounds and compositions of Formulas and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).
    Type: Application
    Filed: February 27, 2017
    Publication date: June 15, 2017
    Inventors: Jennifer Golden, Jeffrey Aube, Donghoon Chung, Chad Schroeder, Tuanli Yao, E. Lucile White, Nichole A. Tower
  • Patent number: 9580393
    Abstract: The present technology relates to compounds and compositions of Formulas I-III and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: February 28, 2017
    Assignees: UNIVERSITY OF KANSAS, UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC., SOUTHERN RESEARCH INSTITUTE
    Inventors: Jennifer Golden, Jeffrey Aube, Donghoon Chung, Chad Schroeder, Tuanli Yao, E. Lucile White, Nichole A. Tower
  • Publication number: 20150329499
    Abstract: The present technology relates to compounds and compositions of Formulas I-III and methods using such compounds. The compounds and compositions described herein may be used in the treatment or prophylaxis of diseases associated with an alphavirus, for example, Venezuelan equine encephalitis virus (VEEV).
    Type: Application
    Filed: December 13, 2013
    Publication date: November 19, 2015
    Inventors: Jennifer Golden, Jeffrey Aube, Donghoon Chung, Chad Schroeder, Tuanli Yao, E. Lucile White, Nichole A. Tower